Cargando…
Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine
Autores principales: | Gershman, Mark D., Sotir, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657809/ https://www.ncbi.nlm.nih.gov/pubmed/28749924 http://dx.doi.org/10.15585/mmwr.mm6629a4 |
Ejemplares similares
-
Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017
por: Gershman, Mark D., et al.
Publicado: (2017) -
Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA
por: Rojas, Andrey, et al.
Publicado: (2023) -
Travel Characteristics and Yellow Fever Vaccine Usage Among US Global TravEpiNet Travelers Visiting Countries with Risk of Yellow Fever Virus Transmission, 2009–2011
por: Jentes, Emily S., et al.
Publicado: (2013) -
Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?
por: de Jong, Wesley, et al.
Publicado: (2019) -
YELLOW FEVER VACCINATION ESSENTIAL FOR ANGOLA, WHO REMINDS TRAVELLERS
Publicado: (2016)